abvd vs. escbeacopp in hl: a 10-year study
Published 6 years ago • 2.3K plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:37
brecadd versus beacopp in advanced hl: a german hodgkin study group investigation
-
1:47
updates from the hd21 study: escalated beacopp vs brecadd for the treatment of hl
-
15:57
initial therapy of advanced stage hodgkin lymphoma: when to use abvd, a(bv)vd, and beacopp
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:21
hodgkin lymphoma highlights from ash 2023: nivo-avd versus bv-avd in patients with hl
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
10:49
day 11 of chemo cycle 4 - hodgkin lymphoma
-
16:16
chemotherapie mit der studie hd21 "brecadd schema " 》hodgkin lymphom 》morbus hodgkin
-
3:13
patient case presentation (case #1)
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
2:41
an overview of the latest advances in hematology
-
2:55
post-transplant pd1 blockade plus autologous lymphocytes in r/r hl
-
2:49
improving the activity of bh3 mimetic venetoclax: a case study
-
4:15
advanced hodgkin lymphoma: ahl2011 data update from eha 2018
-
2:20
minimised beacopp exposure and toxicity for hodgkin lymphoma gives good results
-
5:07
daratumumab in the management of al amyloidosis
-
2:27
ascembl: asciminib versus bosutinib in third-line treatment of cp-cml
-
5:18
upfront treatment in transplant candidates
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:19
the potential of caplacizumab in the treatment of attp